This HTML5 document contains 204 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n12http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n9https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q48149391
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ articol științific 2017年學術文章 ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ artigo científico 2017년 논문 tudományos cikk 2017年學術文章 2017年学术文章 سائنسی مضمون научни чланак vitskapeleg artikkel 2017年の論文 artigo científico (publicado na 2017) 2017年學術文章 artículo científico publicado en 2017 scienca artikolo գիտական հոդված 2017年学术文章 2017年學術文章 научна статия articolo scientifico 2017年学术文章 wissenschaftlicher Artikel scientific article published on 12 May 2017 videnskabelig artikel (udgivet 2017) artikulong pang-agham vitenskapelig artikkel article scientifique (publié 2017) teaduslik artikkel 2017年學術文章 наукова стаття, опублікована в травні 2017 επιστημονικό άρθρο artykuł naukowy บทความทางวิทยาศาสตร์ სამეცნიერო სტატია научни чланак tieteellinen artikkeli 2017年学术文章 مقالة علمية نشرت في 12 مايو 2017 2017年学术文章 bilimsel makale bài báo khoa học naučni članak article scientific מאמר מדעי научная статья مقالهٔ علمی scientific article published on 12 May 2017 2017 nî lūn-bûn artículu científicu wetenschappelijk artikel 2017年學術文章 article científic artikel ilmiah artigo científico (publicado na 2017) vetenskaplig artikel mokslinis straipsnis scientific article published on 12 May 2017 artikull shkencor vědecký článek vedecký článok
p:P577
wds:Q48149391-8AD37993-E470-4A45-843B-423C6205D9B4
wdt:P577
2017-05-12T00:00:00Z
p:P2888
wds:Q48149391-8F2C9A86-EAED-4974-9191-C1391ACFEF56
wdt:P2888
n9:s11060-017-2466-0
p:P2860
wds:Q48149391-38D6502C-7DF5-4596-84E2-F5E21587D885 wds:Q48149391-3A099C8A-A7D4-4FDB-82FF-1BEBEF648538 wds:Q48149391-404F1110-0755-47FD-B33A-CE62D0002A75 wds:Q48149391-41D55D55-E809-4CCE-AFA9-2FDBEF7107FD wds:Q48149391-4D1AE7C1-FF66-4F27-A332-A4D069A2327B wds:Q48149391-54772CF9-30B6-4238-BDDE-E9C53897484A wds:Q48149391-574048CF-5A13-4240-A580-6B0D37A3801D wds:Q48149391-58ECCEAF-F7CF-4AC2-933B-2F253816536C wds:Q48149391-5BD3FE92-981B-4243-95A3-DDEBA8B04B78 wds:Q48149391-5F4C86F2-9977-4D4D-9FB7-D6394E8213C0 wds:Q48149391-683E0223-E933-4F4C-978F-9DDEF09E0C42 wds:Q48149391-69B3B8A4-BBBC-44BD-BBCB-599A4A880D73 wds:Q48149391-6AE9147C-7FA8-493A-B828-8FC9FCA19CD9 wds:Q48149391-6CF056F8-64DE-43D0-B6EE-1BBF622B5D52 wds:Q48149391-F2EE626C-62DA-4D3C-A0F8-8AF1BD1A4A5A wds:Q48149391-F69F9CCD-012B-4120-9407-F63DBAE31459 wds:Q48149391-F7FD7C30-BDE4-4639-9BAA-8AC83DC60FF9 wds:Q48149391-9E176D75-AE16-4586-A643-98A37ABA820F wds:Q48149391-A5D48B23-3EF5-427C-969E-3BE5AD336111 wds:Q48149391-A87D8944-A4EC-44E0-BA4F-0EB508AC7ED1 wds:Q48149391-B19EC085-4C3B-47DD-84BF-31D4935714CC wds:Q48149391-B65E5DEA-4437-46F6-971A-C7A508BE1465 wds:Q48149391-C597C115-BA68-4EF3-B7E9-34CA4121B73A wds:Q48149391-CBCD690A-DEDA-432B-9BA0-52AF1B26C53E wds:Q48149391-CF1C2557-6C34-4991-82FA-00276E10BBD9 wds:Q48149391-D958A192-026B-46AC-A5F5-20FE2DB928F6 wds:Q48149391-D9D53C2B-CB72-4FE1-A8A9-CB30CA01FF0B wds:Q48149391-ED9553D0-8B30-4189-9D1F-64989AEFFC07 wds:Q48149391-005D4664-A369-40F6-A21A-B8BA5584B1AB wds:Q48149391-06BA749C-42EC-4094-B9DC-7B77BC1F4B38 wds:Q48149391-07CD74C6-3847-494E-BB90-D2D0674C11DB wds:Q48149391-07F21D59-106D-4282-B532-DBF52E9C71A8 wds:Q48149391-094C0ECE-A0EC-4637-B2B5-BF2772F88E63 wds:Q48149391-09F2EB71-6371-41F8-9099-61AE9FE2C075 wds:Q48149391-211DC282-50A9-4122-AB5C-7DB00941F2A8 wds:Q48149391-27F10F02-70D9-4AC9-8CAF-AAF2A16C054B wds:Q48149391-29280308-76A3-465C-AB78-91FE5627A166 wds:Q48149391-29F715A3-599F-4C4A-9D68-8C1312724936 wds:Q48149391-2FBEE72C-D443-4FE6-8B1D-2DC06FBDF8B1 wds:Q48149391-3035F113-B4BF-45E6-90E7-34BCDEDDA826 wds:Q48149391-312910C5-C69A-49C7-B597-1C93DD0391CC wds:Q48149391-6F25CA39-9866-4DF5-9380-05B6D71686D6 wds:Q48149391-74149F46-208D-43F5-8274-FF48977D3899 wds:Q48149391-75A6A17A-6682-4BB4-9A15-468FE97B9D61 wds:Q48149391-75BE14E7-3494-4726-A347-96491909F989 wds:Q48149391-7A19EAA4-3358-48ED-B2CC-6EB366A66DFB wds:Q48149391-7F6E2DA3-1814-41AB-930B-EC54B52558CF wds:Q48149391-825BDECF-E9D5-488C-B96B-7AC8F37AA856 wds:Q48149391-82BF35DA-6B1B-4AFE-84B7-8F8E350F0E67 wds:Q48149391-8323E0E5-AF1E-4126-9E08-86FA9383DE9D wds:Q48149391-88F7EE0A-2146-44D7-8E85-592110544418 wds:Q48149391-8B5EF718-C9E6-493D-B5CC-D2CCC14A44B4
wdt:P2860
wd:Q34315691 wd:Q29617771 wd:Q48342416 wd:Q29620856 wd:Q33710967 wd:Q38264492 wd:Q36705933 wd:Q48271471 wd:Q38573324 wd:Q34131832 wd:Q43121697 wd:Q37180426 wd:Q45931836 wd:Q28086839 wd:Q33616632 wd:Q41386447 wd:Q52649448 wd:Q36288280 wd:Q46942082 wd:Q24633070 wd:Q31148416 wd:Q33416502 wd:Q29620913 wd:Q36500401 wd:Q26866513 wd:Q29620596 wd:Q33511263 wd:Q35225287 wd:Q29620851 wd:Q29617568 wd:Q37395361 wd:Q30661157 wd:Q43476733 wd:Q48440226 wd:Q41069147 wd:Q42804587 wd:Q33382596 wd:Q41983246 wd:Q37481863 wd:Q34062033 wd:Q29615679 wd:Q36211586 wd:Q27860852 wd:Q35895159 wd:Q36043066 wd:Q46476922 wd:Q55470774 wd:Q27853362 wd:Q38403041 wd:Q28262647 wd:Q33395579 wd:Q34480689
p:P2093
wds:Q48149391-6FF3D329-3BCD-4747-8084-D91B5601E771
wdt:P2093
Bryan T Kim
rdfs:label
Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series. Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.
skos:prefLabel
Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series. Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.
schema:name
Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series. Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.
p:P50
wds:Q48149391-78769DF4-B317-4770-9BF7-C8673CA3AD07
wdt:P50
wd:Q88054225
p:P1476
wds:Q48149391-8E2C18B6-84B8-48ED-9988-172D138AEEEC
wdt:P1476
Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series
p:P304
wds:Q48149391-CB4901D2-A02C-4978-B553-78C4574819B3
wdt:P304
561-569
p:P31
wds:Q48149391-9F2E4577-183A-44BB-BF58-3354C20B62E3
wdt:P31
wd:Q13442814
p:P921
wds:Q48149391-1960FEC2-49BD-4742-8E1C-A28A4B4E181E wds:Q48149391-11BE46CD-653F-4004-96B2-89EF4F56506F
wdt:P921
wd:Q413299 wd:Q282142
p:P698
wds:Q48149391-97DED597-ECB3-430F-9F03-B2540362FC9C
wdtn:P698
n11:28500559
wdt:P698
28500559
p:P1433
wds:Q48149391-AD1321C2-F70E-44B1-8021-E805748AF354
wdt:P1433
wd:Q15752119
p:P433
wds:Q48149391-D4A66EE3-26A2-4A24-8D9D-32204F343148
p:P478
wds:Q48149391-3F3E6791-6F1F-4FE3-B24D-CD704FC9EA31
wdt:P433
3
wdt:P478
133
p:P356
wds:Q48149391-4622EF24-58E4-42EA-934B-1FA01A5D0678
wdtn:P356
n12:S11060-017-2466-0
wdt:P356
10.1007/S11060-017-2466-0